» Articles » PMID: 37090284

Quantum of Stress Hyperglycemia at the Time of Initial Diagnosis of Tuberculosis

Overview
Journal Cureus
Date 2023 Apr 24
PMID 37090284
Authors
Affiliations
Soon will be listed here.
Abstract

Background India has a high burden of both tuberculosis (TB) and diabetes mellitus (DM). The National TB Elimination Program recommends testing for glycemic status at the initiation of therapy; however, some individuals with elevated sugar levels might have stress hyperglycemia (SH) instead of true DM. Our aim was to perform a longitudinal glycemic assessment of individuals with TB to identify those with true newly diagnosed DM and those with SH. Methods We identified newly diagnosed adults with TB and abstracted information about demography, co-morbidities, disease severity, and glucose-lowering agents. A glycemic assessment was performed at baseline and at the end of six months. Results We included 150 patients with TB, and based on their initial HbA1c values, 82 (54.6%, 95% CI: 46-62%) had dysglycemia (30% had HbA1c levels above 6.4% and 24.6% had values between 5.9% and 6.4%) and 31 (20.7%, 95% CI: 14-18%) had SH. Among individuals with both baseline and follow-up glycemic values, 30% of the individuals previously defined as DM were characterized as SH. The proportion of true SH was 43% (95% CI: 33-60%). Conclusion Most individuals who have dysglycemia at the time of their TB diagnosis have SH. A close follow-up of such individuals will identify those who really require long-term glucose-lowering therapy.

References
1.
Tabarsi P, Baghaei P, Marjani M, Vollmer W, Masjedi M, Harries A . Changes in glycosylated haemoglobin and treatment outcomes in patients with tuberculosis in Iran: a cohort study. J Diabetes Metab Disord. 2015; 13(1):123. PMC: 4280034. DOI: 10.1186/s40200-014-0123-0. View

2.
Kumpatla S, Aravindalochanan V, Rajan R, Viswanathan V, Kapur A . Evaluation of performance of A1c and FPG tests for screening newly diagnosed diabetes defined by an OGTT among tuberculosis patients-a study from India. Diabetes Res Clin Pract. 2013; 102(1):60-4. DOI: 10.1016/j.diabres.2013.08.007. View

3.
Kornfeld H, West K, Kane K, Kumpatla S, Zacharias R, Martinez-Balzano C . High Prevalence and Heterogeneity of Diabetes in Patients With TB in South India: A Report from the Effects of Diabetes on Tuberculosis Severity (EDOTS) Study. Chest. 2016; 149(6):1501-8. PMC: 4944775. DOI: 10.1016/j.chest.2016.02.675. View

4.
Marik P, Bellomo R . Stress hyperglycemia: an essential survival response!. Crit Care. 2013; 17(2):305. PMC: 3672537. DOI: 10.1186/cc12514. View

5.
Williams V, Onwuchekwa C, Vos A, Grobbee D, Otwombe K, Klipstein-Grobusch K . Tuberculosis treatment and resulting abnormal blood glucose: a scoping review of studies from 1981 - 2021. Glob Health Action. 2022; 15(1):2114146. PMC: 9543146. DOI: 10.1080/16549716.2022.2114146. View